HAEM5:Volunteer Assignments and Opportunities
| Disease (5th Edition) | Page Type | Author (5th edition) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Author Content (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review | Notes | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS) |
|
|
|||||||||
| Clonal haematopoiesis | Disease | Fabiola Quintero-Rivera (FQR) | |||||||||
| Clonal cytopenias of undetermined significance | Disease | FQR | |||||||||
| Chronic myeloid leukaemia | Disease | Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | FQR | ||||||||
| Chronic neutrophilic leukaemia | Disease | Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally | FQR | ||||||||
| Chronic eosinophilic leukaemia | Disease | Chelsea D. Kramish; Daynna J.Wolff Pending Review* | FQR | ||||||||
| Polycythaemia vera | Disease | Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center | FQR | ||||||||
| Essential thrombocythaemia | Disease | Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | FQR | ||||||||
| Primary myelofibrosis | Disease | T. Niroshi Senaratne, UCLA | FQR | ||||||||
| Juvenile myelomonocytic leukaemia | Disease | Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories | FQR | ||||||||
| Myeloproliferative neoplasm, NOS | Disease | Thomas Lee, MD, PhD, University of California, Los Angeles | FQR | ||||||||
| Cutaneous mastocytosis | Disease | S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD | FQR | ||||||||
| Systemic mastocytosis | Disease | Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University | FQR | ||||||||
| Mast cell sarcoma | Disease | Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL | FQR | ||||||||
| Myelodysplastic neoplasm with low blasts and 5q deletion | Disease | FQR | |||||||||
| Myelodysplastic neoplasm with low blasts and SF3B1 mutation | Disease | FQR | |||||||||
| Myelodysplastic neoplasm with biallelic TP53 inactivation | Disease | FQR | |||||||||
| Myelodysplastic neoplasm with low blasts | Disease | FQR | |||||||||
| Myelodysplastic neoplasm, hypoplastic | Disease | FQR | |||||||||
| Myelodysplastic neoplasm with increased blasts | Disease | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. | FQR | ||||||||
| Childhood myelodysplastic neoplasm with low blasts | Disease | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. | FQR | ||||||||
| Childhood myelodysplastic neoplasm with increased blasts | Disease | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. | FQR | ||||||||
| Chronic myelomonocytic leukaemia | Disease | Linsheng Zhang, MD, PhD | FQR | ||||||||
| Myelodysplastic/myeloproliferative neoplasm with neutrophilia | Disease | Linsheng Zhang, MD, PhD | FQR | ||||||||
| Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | Disease | Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | FQR | ||||||||
| Myelodysplastic/myeloproliferative neoplasm, NOS | Disease | Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia | FQR | ||||||||
| Myeloid/lymphoid neoplasm with PDGFRA rearrangement | Disease | Jay Alden, DO | FQR | ||||||||
| Myeloid/lymphoid neoplasm with PDGFRB rearrangement | Disease | Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD | FQR | ||||||||
| Myeloid/lymphoid neoplasm with FGFR1 rearrangement | Disease | Yanna Ding, MD PhD | FQR | ||||||||
| Myeloid/lymphoid neoplasm with JAK2 rearrangement | Disease | Jessica Snider, M.D. and Daynna J. Wolff, PhD | FQR | ||||||||
| Myeloid/lymphoid neoplasm with FLT3 rearrangement | Disease | FQR | |||||||||
| Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion | Disease | FQR | |||||||||
| Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes | Disease | FQR | |||||||||
| Acute promyelocytic leukaemia with PML::RARA fusion | Disease | Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. | Jennelle Hodge (JH)/ Malini Sathanoori (MS) | ||||||||
| Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | Disease | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
JH_MS | ||||||||
| Acute myeloid leukaemia with CBFB::MYH11 fusion | Disease | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
JH_MS | ||||||||
| Acute myeloid leukaemia with DEK::NUP214 fusion | Disease | JH_MS | |||||||||
| Acute myeloid leukaemia with RBM15::MRTFA fusion | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | ||||||||
| Acute myeloid leukaemia with BCR::ABL1 fusion | Disease | Kay Weng Choy MBBS, Monash Medical Centre | JH_MS | ||||||||
| Acute myeloid leukaemia with KMT2A rearrangement | Disease | Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. | JH_MS | ||||||||
| Acute myeloid leukaemia with MECOM rearrangement | Disease | JH_MS | |||||||||
| Acute myeloid leukaemia with NUP98 rearrangement | Disease | JH_MS | |||||||||
| Acute myeloid leukaemia with NPM1 mutation | Disease | Xinjie Xu, PhD, FACMG | JH_MS | ||||||||
| Acute myeloid leukaemia with CEBPA mutation | Disease | Paul Defazio, MSc, Monash Health | JH_MS | ||||||||
| Acute myeloid leukaemia, myelodysplasia-related | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | ||||||||
| Acute myeloid leukaemia with other defined genetic alterations | Disease | JH_MS | |||||||||
| Acute myeloid leukaemia with minimal differentiation | Disease | Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | JH_MS | ||||||||
| Acute myeloid leukaemia without maturation | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | ||||||||
| Acute myeloid leukaemia with maturation | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | ||||||||
| Acute basophilic leukaemia | Disease | Ashwini Yenamandra PhD FACMG | JH_MS | ||||||||
| Acute myelomonocytic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | ||||||||
| Acute monocytic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | ||||||||
| Acute erythroid leukaemia | Disease | Ashwini Yenamandra PhD FACMG | JH_MS | ||||||||
| Acute megakaryoblastic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | ||||||||
| Myeloid sarcoma | Disease | Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | JH_MS | ||||||||
| Myeloid neoplasm post cytotoxic therapy | Disease | Shawn A. Silver, DO, Shashi Shetty, Ph.D. | JH_MS | ||||||||
| Myeloid neoplasms associated with germline predisposition | Disease | JH_MS | |||||||||
| Myeloid proliferations associated with Down syndrome | Disease | Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | JH_MS | ||||||||
| Mixed-phenotype acute leukaemia with BCR::ABL1 fusion | Disease | Tracy Tucker, PhD, FCCMG | JH_MS | ||||||||
| Mixed-phenotype acute leukaemia with KMT2A rearrangement | Disease | Tracy Tucker, PhD, FCCMG | JH_MS | ||||||||
| Acute leukaemia of ambiguous lineage with other defined genetic alterations | Disease | JH_MS | |||||||||
| Mixed-phenotype acute leukaemia, B/myeloid | Disease | Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | JH_MS | ||||||||
| Mixed-phenotype acute leukaemia, T/myeloid | Disease | Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | JH_MS | ||||||||
| Mixed-phenotype acute leukaemia, rare types | Disease | Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | JH_MS | ||||||||
| Acute leukaemia of ambiguous lineage, NOS | Disease | JH_MS | |||||||||
| Acute undifferentiated leukaemia | Disease | Amelia Nakanishi, MD and Shashi Shetty, PhD | JH_MS | ||||||||
| CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) |
|
|
|||||||||
| Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm | Disease | Greg Corboy (GC) | |||||||||
| Blastic plasmacytoid dendritic cell neoplasm | Disease | Hao Liu, MD and Daynna J. Wolff, PhD | GC | ||||||||
| Langerhans cell histiocytosis | Disease | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | GC | ||||||||
| Langerhans cell sarcoma | Disease | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | GC | ||||||||
| Indeterminate dendritic cell tumour | Disease | GC | |||||||||
| Interdigitating dendritic cell sarcoma | Disease | GC | |||||||||
| Juvenile xanthogranuloma | Disease | GC | |||||||||
| Erdheim-Chester disease | Disease | GC | |||||||||
| Rosai-Dorfman Disease | Disease | GC | |||||||||
| ALK-positive histiocytosis | Disease | GC | |||||||||
| Histiocytic sarcoma | Disease | Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | GC | ||||||||
| CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
|||||||||
| Reactive B-cell rich lymphoid proliferations that can mimic lymphoma | Disease | GC | |||||||||
| IgG4-related disease | Disease | GC | |||||||||
| Unicentric Castleman disease | Disease | GC | |||||||||
| Idiopathic multicentric Castleman disease | Disease | GC | |||||||||
| KSHV/HHV8-associated multicentric Castleman disease | Disease | Sudha Arumugam, MD | GC | ||||||||
| B-lymphoblastic leukaemia/lymphoma | Disease | Holli Drendel (HD) | |||||||||
| B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy | Disease | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | HD | ||||||||
| B-lymphoblastic leukaemia/lymphoma with hypodiploidy | Disease | Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG | HD | ||||||||
| B-lymphoblastic leukaemia/lymphoma with iAMP21 | Disease | Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | HD | ||||||||
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion | Disease | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | HD | ||||||||
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features | Disease | Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine | HD | ||||||||
| B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement | Disease | Yassmine Akkari Nicolas Millan | HD | ||||||||
| B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Disease | Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma | HD | ||||||||
| B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features | Disease | HD | |||||||||
| B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion | Disease | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | HD | ||||||||
| B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion | Disease | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | HD | ||||||||
| B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion | Disease | HD | |||||||||
| B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations | Disease | HD | |||||||||
| B-lymphoblastic leukaemia/lymphoma, NOS | Disease | HD | |||||||||
| Monoclonal B-cell lymphocytosis | Disease | Shivani Golem (SG) | |||||||||
| Chronic lymphocytic leukaemia/small lymphocytic lymphoma | Disease | Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD | SG | ||||||||
| Hairy cell leukaemia | Disease | *Snehal Patel, MD, PhD | SG | ||||||||
| Splenic marginal zone lymphoma | Disease | *Snehal Patel, MD, PhD | SG | ||||||||
| Splenic diffuse red pulp small B-cell lymphoma | Disease | *Snehal Patel, MD, PhD | SG | ||||||||
| Splenic B-cell lymphoma/leukaemia with prominent nucleoli | Disease | *Snehal Patel, MD, PhD | SG | ||||||||
| Lymphoplasmacytic lymphoma | Disease | Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | SG | ||||||||
| Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Disease | SG | |||||||||
| Primary cutaneous marginal zone lymphoma | Disease | SG | |||||||||
| Nodal marginal zone lymphoma | Disease | Andrew Ly, DO and Shivani Golem, PhD, FACMG | SG | ||||||||
| Paediatric nodal marginal zone lymphoma | Disease | * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | SG | ||||||||
| In situ follicular B-cell neoplasm | Disease | Rachel D. Burnside, PhD, MBA, FACMGG | SG | ||||||||
| Follicular lymphoma | Disease | Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | SG | ||||||||
| Paediatric-type follicular lymphoma | Disease | *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | SG | ||||||||
| Duodenal-type follicular lymphoma | Disease | SG | |||||||||
| Primary cutaneous follicle centre lymphoma | Disease | Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | SG | ||||||||
| In situ mantle cell neoplasm | Disease | Rina Kansal, MD; Versiti Blood Center of Wisconsin | SG | ||||||||
| Mantle cell lymphoma | Disease | * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | SG | ||||||||
| Leukaemic non-nodal mantle cell lymphoma | Disease | SG | |||||||||
| Transformations of indolent B-cell lymphomas | Disease | SG | |||||||||
| Diffuse large B-cell lymphoma, NOS | Disease | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | GC | ||||||||
| T-cell/histiocyte-rich large B-cell lymphoma | Disease | GC | |||||||||
| Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements | Disease | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | GC | ||||||||
| ALK-positive large B-cell lymphoma | Disease | Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) | GC | ||||||||
| Large B-cell lymphoma with IRF4 rearrangement | Disease | *Afia Hasnain, MBBS, PhD | GC | ||||||||
| High grade B-cell lymphoma with 11q aberrations | Disease | Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | GC | ||||||||
| Lymphomatoid granulomatosis | Disease | GC | |||||||||
| EBV-positive diffuse large B-cell lymphoma | Disease | GC | |||||||||
| Diffuse large B-cell lymphoma associated with chronic inflammation | Disease | GC | |||||||||
| Fibrin-associated large B-cell lymphoma | Disease | GC | |||||||||
| Fluid overload-associated large B-cell lymphoma | Disease | GC | |||||||||
| Plasmablastic lymphoma | Disease | Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | GC | ||||||||
| Primary large B-cell lymphoma of immune-privileged sites | Disease | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | GC | ||||||||
| Primary cutaneous diffuse large B-cell lymphoma, leg type | Disease | GC | |||||||||
| Intravascular large B-cell lymphoma | Disease | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | GC | ||||||||
| Primary mediastinal large B-cell lymphoma | Disease | GC | |||||||||
| Mediastinal grey zone lymphoma | Disease | GC | |||||||||
| High-grade B-cell lymphoma, NOS | Disease | Aiko Otsubo, PhD, Indiana University | GC | ||||||||
| Burkitt lymphoma | Disease | Becky Leung, MBBS (Hons), BSc, Pathology Queensland | GC | ||||||||
| Primary effusion lymphoma | Disease | GC | |||||||||
| KSHV/HHV8-positive diffuse large B-cell lymphoma | Disease | GC | |||||||||
| KSHV/HHV8-positive germinotropic lymphoproliferative disorder | Disease | GC | |||||||||
| Hyperplasias arising in immune deficiency/dysregulation | Disease | GC | |||||||||
| Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | Disease | Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | GC | ||||||||
| EBV-positive mucocutaneous ulcer | Disease | GC | |||||||||
| Lymphomas arising in immune deficiency / dysregulation | Disease | GC | |||||||||
| Inborn error of immunity-associated lymphoid proliferations and lymphomas | Disease | GC | |||||||||
| Classic Hodgkin lymphoma | Disease | Patricia V. Hernandez, M.D., Washington University School of Medicine | GC | ||||||||
| Nodular lymphocyte predominant Hodgkin lymphoma | Disease | GC | |||||||||
| Cold agglutinin disease | Disease | SG | |||||||||
| IgM monoclonal gammopathy of undetermined significance | Disease | SG | |||||||||
| Non-IgM monoclonal gammopathy of undetermined significance | Disease | SG | |||||||||
| Monoclonal gammopathy of renal significance | Disease | SG | |||||||||
| Immunoglobulin-related (AL) amyloidosis | Disease | Heather E. Williams, PhD, MS, PgD, ErCLG | SG | ||||||||
| Monoclonal immunoglobulin deposition disease | Disease | Chen Yang, MD, PhD, University of Michigan | SG | ||||||||
| Mu heavy chain disease | Disease | SG | |||||||||
| Gamma heavy chain disease | Disease | Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | SG | ||||||||
| Alpha heavy chain disease | Disease | SG | |||||||||
| Plasmacytoma | Disease | SG | |||||||||
| Plasma cell myeloma / multiple myeloma | Disease | *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | SG | ||||||||
| Plasma cell neoplasms with associated paraneoplastic syndrome | Disease | Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD | SG | ||||||||
| CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
|||||||||
| Kikuchi-Fujimoto disease | Disease | Sumi Kitahara (SK) | |||||||||
| Autoimmune lymphoproliferative syndrome | Disease | SK | |||||||||
| Indolent T-lymphoblastic proliferation | Disease | SK | |||||||||
| T-lymphoblastic leukaemia / lymphoma, NOS | Disease | HD | |||||||||
| Early T-precursor lymphoblastic leukaemia / lymphoma | Disease | Fei Yang, MD, FACMG, Kaiser Permanente Northwest | HD | ||||||||
| T-prolymphocytic leukaemia | Disease | SK | |||||||||
| T-large granular lymphocytic leukaemia | Disease | *Michelle Don, MD, MS | SK | ||||||||
| NK-large granular lymphocytic leukaemia | Disease | Michelle Don, MD | SK | ||||||||
| Adult T-cell leukaemia/lymphoma | Disease | Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center | SK | ||||||||
| Sezary syndrome | Disease | Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina | SK | ||||||||
| Aggressive NK-cell leukaemia | Disease | Shanelle De Lancy, MD, Shashirekha Shetty, PhD | SK | ||||||||
| Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | Disease | SK | |||||||||
| Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder | Disease | SK | |||||||||
| Mycosis fungoides | Disease | Jane Scribner, MD and Daynna J. Wolff, PhD | SK | ||||||||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis | Disease | SK | |||||||||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma | Disease | Theresa Spivey, MD, Shashirekha Shetty, PhD | SK | ||||||||
| Subcutaneous panniculitis-like T-cell lymphoma | Disease | SK | |||||||||
| Primary cutaneous gamma/delta T-cell lymphoma | Disease | SK | |||||||||
| Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | Disease | SK | |||||||||
| Primary cutaneous peripheral T-cell lymphoma, NOS | Disease | SK | |||||||||
| Indolent T-cell lymphoma of the gastrointestinal tract | Disease | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | SK | ||||||||
| Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | Disease | SK | |||||||||
| Enteropathy-associated T-cell lymphoma | Disease | *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | SK | ||||||||
| Monomorphic epitheliotropic intestinal T-cell lymphoma | Disease | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | SK | ||||||||
| Intestinal T-cell lymphoma, NOS | Disease | Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) | SK | ||||||||
| Hepatosplenic T-cell lymphoma | Disease | *Michelle Don, MD, MS | SK | ||||||||
| ALK-positive anaplastic large cell lymphoma | Disease | SK | |||||||||
| ALK-negative anaplastic large cell lymphoma | Disease | Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA | SK | ||||||||
| Breast implant-associated anaplastic large cell lymphoma | Disease | Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | SK | ||||||||
| Nodal TFH cell lymphoma, angioimmunoblastic-type | Disease | * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG | SK | ||||||||
| Nodal TFH cell lymphoma, follicular-type | Disease | SK | |||||||||
| Nodal TFH cell lymphoma, NOS | Disease | Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD | SK | ||||||||
| Peripheral T-cell lymphoma, NOS | Disease | SK | |||||||||
| EBV-positive nodal T- and NK-cell lymphoma | Disease | SK | |||||||||
| Extranodal NK/T-cell lymphoma | Disease | SK | |||||||||
| Severe mosquito bite allergy | Disease | SK | |||||||||
| Hydroa vacciniforme lymphoproliferative disorder | Disease | SK | |||||||||
| Systemic chronic active EBV disease | Disease | SK | |||||||||
| Systemic EBV-positive T-cell lymphoma of childhood | Disease | *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA | SK | ||||||||
| CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES) |
|
|
|||||||||
| Follicular dendritic cell sarcoma | Disease | Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG | GC | ||||||||
| EBV-positive inflammatory follicular dendritic cell sarcoma | Disease | GC | |||||||||
| Fibroblastic reticular cell tumour | Disease | GC | |||||||||
| Intranodal palisaded myofibroblastoma | Disease | GC | |||||||||
| Littoral cell angioma | Disease | GC | |||||||||
| Splenic hamartoma | Disease | GC | |||||||||
| Sclerosing angiomatoid nodular transformation (SANT) of spleen | Disease | GC | |||||||||
| CHAPTER 7 (GENETIC TUMOUR SYNDROMES) |
|
|
|||||||||
| Fanconi anaemia | Disease | NA | |||||||||
| Bloom syndrome | Disease | NA | |||||||||
| Ataxia-telangiectasia syndrome | Disease | NA | |||||||||
| RASopathies | Disease | NA |